1. Identification of a New Cholesterol-Binding Site within the IFN-γ Receptor that is Required for Signal Transduction
- Author
-
Ornella Morana, Jon Ander Nieto‐Garai, Patrik Björkholm, Jorge Bernardino de la Serna, Oihana Terrones, Aroa Arboleya, Dalila Ciceri, Iratxe Rojo‐Bartolomé, Cédric M. Blouin, Christophe Lamaze, Maier Lorizate, Francesc‐Xabier Contreras, Bill and Melinda Gates Foundation, Biotechnology and Biological Sciences Research Council, Biotechnology and Biological Sciences Research Cou, Ministerio de Economía y Competitividad (España), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Eusko Jaurlaritza, Fundación Ramón Areces, Fundación Biofísica Bizkaia, Agence Nationale de la Recherche (France), Bill & Melinda Gates Foundation, Biotechnology and Biological Sciences Research Council (UK), and European Commission
- Subjects
PD-L1 ,EXPRESSION ,Technology ,General Chemical Engineering ,Chemistry, Multidisciplinary ,Materials Science ,General Physics and Astronomy ,Medicine (miscellaneous) ,PROTEIN ,Materials Science, Multidisciplinary ,ORGANIZATION ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,lipid nanodomains ,ACTIVATION ,protein-lipid interactions ,Interferon-gamma ,Animals ,Humans ,General Materials Science ,Nanoscience & Nanotechnology ,IMAGE CORRELATION SPECTROSCOPY ,Receptors, Interferon ,Mammals ,Science & Technology ,Binding Sites ,General Engineering ,cholesterol ,Lipids ,Chemistry ,LIPID RAFTS ,Cholesterol ,Physical Sciences ,Science & Technology - Other Topics ,lipids (amino acids, peptides, and proteins) ,interferon gamma receptors ,signal transduction ,Signal Transduction - Abstract
The cytokine interferon-gamma (IFN-γ) is a master regulator of innate and adaptive immunity involved in a broad array of human diseases that range from atherosclerosis to cancer. IFN-γ exerts it signaling action by binding to a specific cell surface receptor, the IFN-γ receptor (IFN-γR), whose activation critically depends on its partition into lipid nanodomains. However, little is known about the impact of specific lipids on IFN-γR signal transduction activity. Here, a new conserved cholesterol (chol) binding motif localized within its single transmembrane domain is identified. Through direct binding, chol drives the partition of IFN-γR2 chains into plasma membrane lipid nanodomains, orchestrating IFN-γR oligomerization and transmembrane signaling. Bioinformatics studies show that the signature sequence stands for a conserved chol-binding motif presented in many mammalian membrane proteins. The discovery of chol as the molecular switch governing IFN-γR transmembrane signaling represents a significant advance for understanding the mechanism of lipid selectivity by membrane proteins, but also for figuring out the role of lipids in modulating cell surface receptor function. Finally, this study suggests that inhibition of the chol-IFNγR2 interaction may represent a potential therapeutic strategy for various IFN-γ-dependent diseases., This work was supported by grants from the Spanish Ministry of Science, Innovation, and Universities (BFU-2015-68981-P and PID2020-117405GB-I00) and the Basque Government (IT1264-19, IT1625-22) to F.-X.C. and M.L. F.-X.C. acknowledge the generous support of Fundación Ramón Areces (grant CIVP20S11276). O.T. was supported by a Basque Government grant (IT1270-19) I.R.-B., O.M., J.A.N.-G., and D.C. were supported by the Fundación Biofisica Bizkaia. The Lamaze laboratory was supported from Agence Nationale de la Recherche grants ANR-11-LABX-0038, ANR-10-IDEX-0001-02, and ANR NanoGammaR-15-CE11-0025-01. The Bernardino de la Serna Lab acknowledges support from Belinda and Bill Gates Foundation and BBSRC (INV-016631 and BB/V019791/1, respectively). This work was supported in part by the Fundación Biofísica Bizkaia and the Basque Excellence Research Centre (BERC) program of the Basque Government. The authors thank the European funding (ERDF and ESF).
- Published
- 2022